Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.

Autor: Seckinger, Anja1 (AUTHOR), Majocchi, Sara2 (AUTHOR), Moine, Valéry2 (AUTHOR), Nouveau, Lise2 (AUTHOR), Ngoc, Hoang3 (AUTHOR), Daubeuf, Bruno2 (AUTHOR), Ravn, Ulla2 (AUTHOR), Pleche, Nicolas2 (AUTHOR), Calloud, Sebastien2 (AUTHOR), Broyer, Lucile2 (AUTHOR), Cons, Laura2 (AUTHOR), Lesnier, Adeline2 (AUTHOR), Chatel, Laurence2 (AUTHOR), Papaioannou, Anne2 (AUTHOR), Salgado-Pires, Susana2 (AUTHOR), Krämer, Sebastian4 (AUTHOR), Gockel, Ines4 (AUTHOR), Lordick, Florian5 (AUTHOR), Masternak, Krzysztof2 (AUTHOR), Poitevin, Yves2 (AUTHOR)
Zdroj: Journal of Hematology & Oncology. 12/12/2023, Vol. 16 Issue 1, p1-23. 23p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje